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Abstract 
Objective: The objective of this selective EBM is to determine whether or not resistance training 
is effective in improving mobility for patients with Parkinson’s disease. 
Study Design: Review of four English language randomized control trials (RCT) published 
between 2012-2013. 
Data Sources: Articles used were RCTs and published in peer reviewed journals and found using 
Pubmed, JAMA, and NCBI. 
Outcomes Measured: Effectiveness was measured by comparing a sham, or non-resistance based 
exercise group, to a resistance based group.  Improvement in mobility was measured using 
UPDRS-III scores. 
Results: Patients with Parkinson’s have slow and weak movements which should be improved 
with resistance training.  Corcos et al showed that resistance training improved UPDRS-III over 
a comparison group with a mean difference of 7.3 points (P<0.001).  Shulman et al showed that a 
stretching and resistance group decreased UPDRS-III scores by 3.5 points (P<0.05) compared to 
a control group.  Park et al showed that the experimental group did not show improvement over a 
comparison group based on UPDRS-III scores and did not have clinically significant outcomes 
(P=0.80).  
Outcome: Resistance training is likely to improve mobility in patients with Parkinson’s Disease 
when compared to control groups and with a minimal risk of harm. 
Key Words: “Parkinson’s Disease,” “Resistance training,” “Treatments.” 
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Introduction 
Parkinson’s Disease (PD) is the second most common neurodegenerative disease in the 
U.S.  PD changes the lives of patients affected through a series of symptoms which decrease 
mobility and independence.  The pathognomonic symptoms of the disease are tremor, weakness, 
rigidity, bradykinesia, and gait disturbance; all of which contribute to a decrease in patient 
mobility.1  These disturbances are thought to be caused by a deficiency in dopaminergic neurons.  
In patients with PD, these neurons are found to be depleted and those remaining contain Lewy 
body inclusions in the substantia nigra.1  There is also reduced cerebral blood flow and blood 
oxygenation dependent activation in the striatum, prefrontal cortex, and supplementary motor 
area.2  This means that when attempting motor skills, basal ganglia neurons of PD patients are 
hypoactive; reducing function.2 
  PD is an enormous financial and resource burden on the U.S. health system.  According 
to Kowal et al,3 Parkinson’s disease affects around 630,000 people in the U.S. and will double by 
the year 2040.  In 2010 this disease contributed $14 billion to health care costs and is expected to 
increase with a growing elderly population.3  In 2010, PD patients incurred 1.26 million 
physician office visits and 31,000 emergency department visits.3  Additionally, 9% of nursing 
home patients had a diagnosis of PD.3 
Parkinson’s is more common in men than in women, and risk factors include old age, 
family history, rural lifestyle, and pesticide exposure.4  While the exact cause is unknown, it is 
believed to occur from a combination of genetic and environmental influences.4  Most patients 
initially present between 55-65 years old with resting tremor being the most common initial 
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symptom.4  Diagnosis is made clinically with the signs of tremor, gait disturbance, rigidity, and 
bradykinesia.1 
Current treatments are non-curative and focus on improvement of motor symptoms.  The 
current recommended pharmacologic treatment is Levodopa; a dopamine precursor shown to 
improve activities of daily living (ADL) and motor function.1  Other pharmacologic treatments 
are dopamine agonists such as pramipexole, ropinirole, or bromocriptine.  These are less 
effective but have no dyskinesia side effects.1  MAO-B inhibitors and Amantadine are also used 
for early symptoms but have moderate effects.1  Surgical treatment is reserved for severe cases 
and consists of deep brain stimulation by implantable electrodes.1  Exercise therapy is also used 
consistently to alleviate symptoms and is most beneficial when implemented early.  Different 
exercise routines have been studied such as treadmill walking, Tai Chi, and resistance training.  
Resistance training is performed by short periods of muscle contraction against an external force 
with intermittent rest; sometimes referred to as high intensity exercise.  This can be performed in 
a fitness center or at home with minimal training.  Because of this it can be easily recommended 
by a healthcare provider at early signs of PD.  Determining the efficacy of this training to 
improve motor symptoms is the focus of this review. 
Resistance exercise therapy is thought to benefit PD in two ways.  Repetitive force 
production by muscles has been shown to increase neuronal activation in the basal ganglia.5  It 
also increases blood-oxygen-level dependent signaling in this region as well as the motor cortex, 
leading to improvement in motor function.5  Both areas are thought to be impaired in PD 
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patients.  In addition, exercise therapy has shown to increase muscle strength and perceived 
quality of life; essential aspects of mobility for anyone with a chronic illness.6 
It is reasonable to think that this type of treatment can improve mobility in patients with 
early, non-debilitating symptoms of PD, and can easily be recommended by midlevel providers 
such as Physician Assistants and Nurse Practitioners.  If resistance based exercise programs are 
successful in improving mobility, they would have a direct impact on patient lives and may even 
improve the economic and resource burden of Parkinson’s. 
The RCTs reviewed here focus on initiating a resistance based exercise program in 
patients with early symptoms of PD compared to either non-resistance type, or sham routines.  
The measurement outcomes of interest are centered on a patient’s ability to maintain mobility, 
which would significantly improve lifestyle.  Along with the physical and mental health benefits 
of resistance training, implementing this type of treatment is a cost effective and practical 
treatment approach that is within the scope of practice of midlevel and advanced providers. 
Objective 
 The objective of this selective EBM is to determine whether or not resistance training is 
effective in improving mobility in patients with Parkinson’s disease. 
Methods 
 The selective research studies chosen had to meet specific criteria in order to be included 
in this review.  The population studied must have been patients over 40 with mild to moderate 
Parkinson’s disease with gait impairment and postural instability and they must maintain 
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physical independence.  Exclusion criteria included cognitive impairments, comorbidities 
preventing exercise, and patients already performing an exercise routine.  The studies measured 
change from baseline mobility of an experimental group and a control group.  Mobility 
measurements included the Unified Parkinson’s Disease Rating Scale with motor sub category 
(UPDRS-III).  Exercise group assignments must have been randomized and patients blinded to 
which group they were in.  Studies were written in English and published in peer reviewed 
journals that could be retrieved through Pubmed, JAMA, and NCBI, and were published no 
earlier than 2012.  Search terms used were “Parkinson’s Disease,” “Resistance Training,” and 
“Treatments.”  Statistical analysis compared mean mobility test scores at baseline and treatment 
completion.  The studies included standard deviations, p-values, and confidence intervals.  
Numbers needed to harm (NNH) with relative (RRI) and absolute risk increase (ARI) could be 
calculated in one of the studies. 
Table 1: Demographics and characteristics of studies 
Study Type Pts Age Included Excluded W/D Intervention
Corcos 
et al.5
RCT 48 50-67 PD, 
dopaminergic 
therapy, stable 
gait
Cognitive 
impairment, co-
morbidities, 
MMSE<23, current 
exercise routine, PD 
surgical treatment
10 Progressive 
resistance 
exercise 
program 
(PRE)
Shulman 
et al.7
RCT 80 >40 PD, Hoehn and 
Yahr 1-3, gait 
impairment
MMSE <23, 
unstable, co-
morbidities, unable 
to walk/exercise
13 Resistance 
Training
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Outcomes Measured 
 The outcome measured to demonstrate mobility in these studies were change from 
baseline UPDRS-III score.  The UPDRS-III motor subscale is graded by an examiner who rates a 
score of 0 for normal, 1 for slight, 2 for mild, 3 for moderate, and 4 for severe as a test taker 
performs specific skills.  These skills include speech, facial expression, resting tremor, action 
tremor, rigidity, finger taping, hand movement, pronation/supination, leg agility, arise from chair, 
posture, gait, posture stability, and bradykinesia.  The lower the UPDRS score, the less disabled a 
person is.  This scoring system is valuable because its components consist of tasks deemed 
necessary for patients to maintain mobility in their daily lifestyle.  It is also easy to understand 
that maintaining these motor functions relates to a wide variety that might be required every day 
in order to maintain physical independence. 
 In all studies chosen, patients were scored at baseline using the above measurements and 
scores were combined using a mean group score.  Experiment and control groups performed the 
assigned exercise programs and UPDRS-III was scored again to measure change from base line.  
Because PD is a progressively disabling disease, maintaining or decreasing the mobility score 
over time would be considered a successful treatment plan.  An increase in score would show 
worsening disease progression and no treatment effect on disease symptoms. 
Results 
Park et 
al.8
RCT 31 40-70 PD with Hoehn 
and Yahr stage 
1-2
Secondary 
condition, Hoehn 
and Yahr > 3, taking 
levodopa
1 Strength 
training
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 Corcos et al began the study with 48 patients from Rush University Medical center and 
performed the evaluations at the University of Illinois Chicago.  Patient’s level of mobility was 
assessed by movement disorder specialists.  The experimental groups performed an 11 exercise 
progressive resistance program targeting all major muscle groups and the control group 
performed a balance and non-progressive strengthening program.  Patients were assessed by 
blinded raters using UPDRS-III scores then randomly assigned to groups.  UPDRS-III scores 
were assessed periodically and at the end of a 24 month period.  At 24 months, the control group 
decreased its mean score by -0.1±8.7 and the experimental group by -7.4±7.4.  After evaluating 
adverse events due to the training program, the experimental group resistance routine had a NNH 
value of 1 injury per -333.3 patients.  Since this is a negative value, it means that 667 people 
need to participate in this training for 1 injury to occur due to training.  The relative risk due to 
injury is -5.7% compared to the control exercise, and absolute risk is -0.3%.  This means that in 
this study there is greater risk for injury in the sham exercise group than the experimental group 
Table 2: Corcos et al UPDRS-III resistance training change from baseline 
Table 3: Corcos et al Numbers Needed to Harm 
Group Baseline Mean
±SD
24 mo  
Mean±SD
Change from 
baseline with CI 
95%
p-value 
<0.001
Control 34.7±11.5 34.0±12.6 -0.1±8.7
Experimental 34.5±11.9 25.8±10.6 -7.4±7.4
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In the study by Shulman et al, a three group comparison of resistance, high intensity, and 
low intensity treadmill exercise were studied.  Participants were recruited by the University of 
Maryland Medical School and assessments were performed at the Baltimore Veteran Affairs 
hospital.  Eighty participants with PD were randomly assigned to one of the three groups.  The 
resistance group performed two sets of 10 repetitions on three different leg exercises three times 
each week for three months and treadmill groups performed 30-50 minute walking sessions on a 
treadmill for the same duration.  Baseline and three month UPDRS-III mean scores with standard 
deviations were obtained.  One-way analysis of variance was used in baseline comparisons 
between groups and post hoc analyses were used for significant changes in group scores.  Only 
the resistance group UPDRS-III change from baseline scores were reported; -3.5 and p-value 
<0.05.  The threshold for a minimally important difference determined by the authors was -2.5 
points.  They reported no change from baseline scores in the two treadmill groups 
 Park et al performed a study using a delayed start design.  This study recruited 31 PD 
patients and randomized them to groups.  Fifteen to the early start group (ESG) and 16 to the 
delayed start group (DSG).  The first six weeks consisted of cardio, core, and joint integrity to 
prevent injury, then the next six weeks focused on strength training.  In the second phase, the 
first two weeks re-focused on cardio/core/joint, then the remainder of the program was devoted 
to strength.  The cycle was repeated and the delayed start group began the routine.  Workouts 
were led by a personal trainer and lasted for one hour, three times each week.  Groups mean 
RRI ARI NNH
-5.7% -.3% -333.3
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UPDRS-III scores with standard deviations were measured at baseline and throughout the study.  
At the end of the study, UPDRS-III scores did not improve for either group.  At 24 weeks, 
UPDRS-III results were insignificant; the ESG increased 2.13±5.43 and the DSG was 0.00±7.45 
with a p-value of 0.49.  At the end of the trial the ESG mean score increased 5.80±4.02 and DSG 
increased 5.27±7.42 with a p-value of 0.80.  The results of this trial did not show an 
improvement in mobility. 
Table 4: Mean UPDRS-III with SD for Park et al ESG and DSG strength training groups 
  
Discussion 
 A recurrent problem in all of these studies is that patients may suspect that they are in an 
experimental or control group based on the type of exercise they are performing.  In the studies 
reviewed, the control groups were given a different exercise which seems to have been an 
acceptable way of disguising the control group.  Another potential weakness is that the UPDRS-
III relies on a rater to assign a subjective value of symptom severity.  While raters were blind to 
group randomization, assuring that the same raters were used for congruency would have 
improved the quality of the studies. 
 In the study by Corcos et al, three patients withdrew from the control group after 
randomization but were replaced before assessment.  After the study measurements began, no 
Group Baseline 24 wks Change p-value 48 wks Change p-value
ESG 14.00±5.73 16.13±6.86 2.13±5.43 .49 20.40±7.01 5.80±4.02 .80
DSG 16.60±7.20 16.60±8.72 0.00±7.45 21.87±10.43 5.27±7.42
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patients were replaced or added to the groups.  The experimental group had 20 complete training 
and the control had 18.  One patient from each group withdrew due to exercise related injury.  By 
calculating the injury event rate in this study, the RRI, ARI, and NNH could be determined for 
this review and is reported in table 3.  With a NNH of -333.3 patients per 1 injury, the risk of an 
adverse event performing this exercise will occur one time for every 667 patients.  Patients that 
withdrew for unrelated reasons were not included.  This study perhaps had the most significant 
results showing that after 24 months, the progressive resistance training group did 7.3 points 
better compared to the control group on UPDRS-III scores.  By lowering the UPDRS-III motor 
scale 7.4 points, the experimental exercise program implemented in this study has shown to 
improve mobility in PD patients.  Even with the SD of 7.4, simply maintaining baseline scores 
over 24 months with a progressive disease can be considered effective treatment. 
 In the Shulman et al study three patients withdrew from the stretch and resistance group 
due to possibly related medical issues with 22 completing the trial.  There were no medical 
related withdrawals from the low intensity treadmill group with 22 completing the trial.  There 
was one withdrawal from the high intensity treadmill group possibly due to exercise and 23 
completed training.  Injury risk data could not be determined in this study because the 
comparison is among three different types of exercises.  The researchers determined that a 
clinically important difference of -2.5 points on the UPDRS motor subscale would be necessary 
to show efficacy of a treatment.  They reported that the both treadmill groups failed to meet this 
difference but did not report exact scores.  Only the stretching and resistance group demonstrated 
improvement in mobility as demonstrated by a 3.5 point decrease in UPDRS-III motor score 
with a 95% CI and p<0.05. 
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 In the study by Park et al, only one patient withdrew in week 32 from the delayed start 
group not related to exercise, leaving 15 patients at final evaluation.  The early start group had no 
attrition and finished with 16 patients.  The delayed start design allowed for researchers to 
compare the intervention being tested to a non-exercise control group as well as show the 
benefits of starting an intervention earlier.  This is beneficial in a disease such as PD in which 
symptoms are chronic and progressively worsen over time.  The results of this study were 
inconclusive.  This study failed to show an improvement in UPDRS-III scores in any group.  The 
small sample size may have attributed to this.  The failure to show statistical significance, using 
95% CI with p-value of 0.80, cannot prove or disprove the efficacy of this treatment protocol.  
Results of this study are reported in table 4. 
Conclusion 
 Based on the evidence examined in these studies, resistance training is likely to improve 
mobility in patients with PD.  Despite two of the three studies lacking statistically significant 
data, the evidence in the other studies show improvement in mobility based on UPDRS-III score.  
The evidence not supporting this preventive treatment does not seem strong enough to cast doubt 
on the other studies.  Furthermore, implementing resistance training is an easy addition to a 
patient’s daily routine.  All of the studies performed showed the negative impact of resistance 
training was minimal and therefore the potential benefit of therapy exceeds any potential risk. 
Performing longer duration exercise routines with larger sample sizes would improve 
these results and could provide further evidence for or against the validity of this treatment.  If 
further research supports the effectiveness of resistance training, it would then be beneficial to 
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compare this to non-exercise based treatments such as medications or surgery.  Studies using 
PET and MRI technology to exam basal ganglia reaction to strength and resistance training 
would also be useful in proving treatment effect on brain physiology as well as motor function. 
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